Dear Colleagues,
I wish to apologise for any offence that may have been caused by the
inappropriate content of the email from Johannes Cramer, which does not
represent the views of the rest of our research group.
With kind regards,
Roman Fedorov
or
cofactor.
I think it depends to a degree on context and history of the field…
Best, BR
From: CCP4 bulletin board [mailto:CCP4BB@JISCMAIL.AC.UK] On Behalf Of Johannes
Cramer
Sent: Wednesday, January 31, 2018 6:34 AM
To: CCP4BB@JISCMAIL.AC.UK
Subject: [ccp4bb] definition of &quo
See also the IUPAC reccomandations :
https://goldbook.iupac.org/html/A/A00417.html
https://goldbook.iupac.org/html/H/H02836.html
---
Stefano Trapani
Maître de Conférences
http://www.cbs.cnrs.fr/index.php/fr/personnel?PERS=Stefano%20Trapani
-
Centre de
Hi Johannes,
this is normal textbook knowledge, which got perverted over time and
misusage. Just check with a serious dictionary like Merrian Webster or
even the Wikipedia (see below).
Best regards,
Xavier
https://www.merriam-webster.com/dictionary/apoenzyme
Dear collegues,
a while ago, there was a discussion in the board on the term apo-structure
as a way to descibe a native, free, or unbound protein (no ligands). I
think the conclusion was that an apo-form is a halo enzyme lacking a
cofactor and should not be used as a substitute for "unbound".
We
